Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

Massey Genome Service (MGS) has invested in two Illumina MiSeq™ instruments. We offer Illumina MiSeq™ sequencing with the following applications: Send the Massey Genome Service (MSG) an email about ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Improvements in the new Illumina platform (HiSeq 2000) include reagent optimization ... which were positioned as instrument vendors, the Complete Genomics business model is to operate as a ...

Illumina, Inc. engages in the development ... The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray ...

CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024 ... driven by increased utilization of NovaSeq X systems. Sequencing instruments revenue totaled $155 million, a 3% ...

San Diego–based Illumina garners the second and third spots with its latest sequencers, one of which (the third-place HiSeq X 10) achieves the long-awaited $1,000 human genome milestone. Other cool ...